Karyopharm Therapeutics KPTI
NASDAQ KPTI
$0.80 -0.07 (-8.05%)
At close: Oct 2, 2026 · 4:00 PM EDT

Karyopharm Therapeutics (KPTI) Invested Capital (2023 - 2026)

Updated

Karyopharm Therapeutics' Invested Capital was -$204.81 million in Q2 2026, compared with -$143.11 million a year earlier.

Analysis

Karyopharm Therapeutics (KPTI) Invested Capital (2023 - 2026) Analysis & Trends

For FY2025, Invested Capital at Karyopharm Therapeutics came in at -$177.12 million.

  • In earlier years, Invested Capital was -$91.41 million in FY2024 and -$136.21 million in FY2023.
  • The Q2 2026 figure marks the lowest quarterly Invested Capital in data going back to Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 88.79 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 134.01 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 64.89 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 95.89 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 79.44 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 50.26 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 68.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 38.08 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 148.69 Bn
10 Karyopharm Therapeutics 23.15 Mn -203.27 Mn 32.35 Mn -204.81 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -204.81 Mn
Dec 31, 2025 -177.12 Mn
Sep 30, 2025 -172.86 Mn
Jun 30, 2025 -143.11 Mn
Mar 31, 2025 -110.69 Mn
Dec 31, 2024 -91.41 Mn
Sep 30, 2024 -65.54 Mn
Jun 30, 2024 -38.62 Mn
Dec 31, 2023 -136.21 Mn
API Access

Karyopharm Therapeutics Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=KPTI&period=max&api_key=YOUR_API_KEY